期刊文献+

原核表达系统制备HPV58L1 VLP可诱发高滴度且持久的中和抗体

Human Papillomavirus Type 58 L1 Virus-Like Particles Produced in Prokaryotic System Elicit High Level of Long-lasting Specific Neutralizing Antibodies
原文传递
导出
摘要 目的:采用大肠杆菌表达系统制备人乳头瘤病毒58型(human papillomavirus type 58,HPV58)病毒样颗粒(virus-like particle,VLP)疫苗。方法:合成法获得HPV58 L1大肠杆菌密码子优化基因,构建HPV58 L1重组原核表达质粒mpET22b/HPV58 L1,检测其在BL21(DE3)中表达水平,饱和硫酸铵沉淀加阳离子交换层析法纯化蛋白后进行动态光散射(dynamic light scatter,DLS)分析。小鼠免疫后,检测免疫血清针对HPV58假病毒的中和抗体水平。结果:HPV58 L1蛋白在BL21(DE3)细胞中大部分以可溶形式表达,纯化获得的HPV58 L1蛋白可组装成水动力学直径约为74 nm的VLP。0.5μg的HPV58 L1 VLP可诱发小鼠产生高滴度的HPV58特异性中和抗体,可维持至少20周。结论:原核表达系统制备的HPV58 L1 VLP可诱发高滴度且持久的中和抗体,可用于成本低的HPV58疫苗的研究。 Objective: To produce human papillomavirus type 58(HPV58) virus-like particles(VLP) vaccine with Escherichia coli expression system. Methods: A synthesized HPV58 L1 gene optimized with bias condons of Escherichia coli was inserted into prokaryotic expression vector mpET22b, and expressed in BL21(DE3). Cells were sonicated and the supernatent was purified with ammonium sulfate precipitation plus cation-exchange chromatography. The purified HPV58 L1 protein was analyzed by dynamic light scatter(DLS), and then immunized mice twice with two week interval. Sera were analyzed with pseudovirion-based neutralization assays. Results: The HPV58 L1 protein was expressed largely in cell lysate and was easy to purify. Dynamic light scattering analysis showed that the mean hydrodynamic diameter of the purified protein was 74 nm, which was similar to that of HPV58 L1 VLP control, indicating the protein was self-assembled into HPV58 L1 VLP. The mean titer of HPV58 neutralizing antibody was as high as 10,000 in sera collected at week 4,and retained 5,000 at week 22. Conclusions: The HPV58 Ll VLP produced in prokaryotic system can induce high titer of long-lerm specific neutralizing antibody, which is a cost-effective candidate of HPV58 prophylatic vaccine.
作者 胡美丽 刘洪洋 王志荣 陈雪 张婷 许雪梅 HU Mei-li, LIU Hong-yang, WANG Zhi-rong, CHEN Xue, ZHANG Ting, XU Xue-mei(Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, 100005, Chin)
出处 《现代生物医学进展》 CAS 2018年第3期419-422,418,共5页 Progress in Modern Biomedicine
基金 国家国际科技合作专项(2013DFA32430) 中国医学科学院医学与健康科技创新工程基金项目(2016-I2M-3-026)
关键词 人乳头瘤病毒58型 大肠杆菌表达系统 病毒样颗粒 中和抗体 Human papillomavirus type 58 Escherichia coli expression system Virus-like particles Neutralizing antibody
  • 相关文献

参考文献2

二级参考文献32

  • 1卢五迅,程通,李少伟,潘晖榕,沈文通,陈毅歆,张涛,郑舟,张军,夏宁邵.人乳头瘤病毒16型假病毒中和实验的建立和初步应用[J].生物工程学报,2006,22(6):990-995. 被引量:13
  • 2Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol, 2005, 32 ( Suppl 1 ) : S16-24. 被引量:1
  • 3Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med, 1997, 102(5A) : 3-8. 被引量:1
  • 4Zhou J, Sun XY, Stenzel D J, et al. Expression of vaccinia recombinant HPV 16 L1 and L20RF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology, 1991,185(1): 251-257. 被引量:1
  • 5Ruiz W, Mcclements WL, Jansen KU, et al. Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 Ll-virus-like particles formulated with or without Merck aluminum adjuvant. J Immune Based Ther Vaccines, 2005, 3 ( 1 ) : 2. 被引量:1
  • 6Villa LL, Costa RL Petta CA, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer, 2006, 95( 11 ) : 1459-1466. 被引量:1
  • 7Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet, 2004, 364(9447) : 1757-1765. 被引量:1
  • 8Rose RC, Reichman RC, Bonnez W. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J Gen Virol, 1994, 75 ( Pt 8) : 2075- 2079. 被引量:1
  • 9Cook JC, Joyce JG, George HA, et al. Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae. Protein Expr Purif, 1999, 17(3) : 477-484. 被引量:1
  • 10Chen XS, Garcea RL, Goldberg I, et al. Structure of small viruslike particles assembled from the L1 protein of human papillomavirus 16. Mol Cell, 2000, 5(3) : 557-567. 被引量:1

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部